InterMune Shares Rise On FDA Panel Recommendation
The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.
gilead
GlaxoSmithKline, Pfizer Team Up Against HIV
The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.